ACT Lung Health Intervention for Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program designed to help Chinese and Korean American smokers quit smoking, aiming to reduce their risk of lung cancer. Participants will either receive the new counseling program (ACT Lung Health Intervention) or standard care while researchers monitor them through surveys and tests over six months. This trial suits current smokers with a long history of smoking who have not recently undergone a specific lung screening test. Participants should also live in the U.S. and have access to a device for video calls.
As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could benefit the community.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this counseling and educational program is safe for improving lung health?
Research has shown that programs designed to help people stop smoking, such as the ACT Lung Health Intervention, are generally manageable for participants. In studies of similar programs, participants have not reported any major side effects. These programs emphasize counseling and education to aid in quitting smoking, without the need for new medications or medical procedures.
Regular check-ins and support sessions are often included, which participants in similar studies have found helpful and safe. Safety concerns remain low because the program employs behavior change techniques instead of new drugs, reducing the risks typically associated with medication trials.
Overall, evidence suggests these programs are safe, with participants primarily experiencing positive outcomes in quitting smoking.12345Why are researchers excited about this trial?
Researchers are excited about the ACT Lung Health Intervention because it takes a fresh approach to helping people quit smoking. Unlike traditional methods like nicotine replacement therapies and prescription medications, this intervention incorporates Acceptance and Commitment Therapy (ACT) principles. ACT focuses on helping individuals accept their cravings and commit to quitting without fighting their urges head-on. This psychological approach, combined with regular support through weekly Zoom sessions and personalized strategies, offers a unique and potentially more effective way to address the emotional and mental challenges of quitting smoking.
What evidence suggests that the ACT Lung Health Intervention is effective for smoking cessation?
Studies have shown that Acceptance and Commitment Therapy (ACT) can help people quit smoking. Research indicates that a smartphone app based on ACT proved more effective in helping users quit than a typical smoking cessation app. Another study found that people using the ACT method were more likely to attempt quitting compared to those using other methods. Typically, without structured help, only about 3%-5% of people successfully quit smoking. In this trial, participants in Group A will receive the ACT Lung Health Intervention, which could be a promising way to support quitting smoking and improve lung health. Meanwhile, participants in Group B will receive standard care.678910
Who Is on the Research Team?
Mary Cooley, PhD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
The ACT Lung Health Intervention trial is for Chinese and Korean American smokers aged 50-80 with a significant smoking history, who currently smoke and have health insurance, a primary healthcare provider, and can video-call. Excluded are those under 50 or over 80, unable to consent, pregnant women, prisoners, recent serious mental illness hospitalization or previous lung cancer.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline visit and initial questionnaires
Intervention
Participants receive counseling and educational program for smoking cessation
Follow-up
Participants are monitored for smoking abstinence and lung cancer screening completion
What Are the Treatments Tested in This Trial?
Interventions
- ACT Lung Health Intervention
Trial Overview
This phase two study tests a counseling and educational program aimed at helping high-risk lung cancer candidates among Chinese and Korean American smokers quit smoking to improve their lung health.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will be randomized 1:1 by block size and stratified by ethnicity and readiness to quit smoking and will complete: * Baseline visit * Questionnaires at 1, 3, and 6 months * 3 month saliva test * Weekly Zoom sessions * 6 month saliva test
Participants will be randomized 1:1 by block size and stratified by ethnicity and readiness to quit smoking and will complete: * Baseline visit * Questionnaires at 1, 3, and 6 months * 3 month saliva test * Weekly Zoom sessions * 6 month saliva test
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
University of Massachusetts, Boston
Collaborator
Citations
A Review of Smoking Cessation Interventions - PubMed Central
Moreover, attempting to quit smoking without any structured approach yielded a mere 3%-5% success rate within the same timeframe [7]. This study ...
Efficacy of Smartphone Applications for Smoking Cessation
This trial provides evidence that, compared with a USCPG-based smartphone application, an ACT-based smartphone application was more efficacious for quitting ...
ACT on Vaping: Pilot Randomized Controlled Trial of a Novel ...
A higher proportion of participants in the ACT on Vaping arm reported a 24-hour quit attempt (87.5% vs. 75.9%), exceeding the efficacy benchmark ...
Comparative effectiveness of mobile health smoking ...
The primary outcome is 7-day point prevalence of smoking abstinence at 6 months. Secondary outcomes are: 12-month smoking abstinence, and patient satisfaction ...
Study Results | Promoting Smoking Cessation in Lung Cancer ...
A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Strategies to deliver smoking cessation interventions during ...
This systematic review addressed the effectiveness of smoking cessation intervention strategies delivered as a component of lung health screening programmes.
Smoking Cessation Interventions in the Lung Cancer ...
This randomized clinical trial evaluates the effectiveness of smoking cessation interventions of varying intensities in the lung cancer ...
Smoking Cessation Pharmacotherapy-Nurse Practitioner ...
The investigators, proposed sample (n= 424 total patients) has 90% power to detect a clinically meaningful 15% improvement in smoking cessation rates at 6 ...
Annals of the American Thoracic Society
We hypothesize that smoking abstinence rates will be higher with the addition of each intervention when compared with arm 1. We will enroll ...
Efficacy and safety of electronic cigarettes as a smoking ...
This systematic review of randomized controlled trials (RCTs) evaluated the efficacy and safety of electronic cigarettes (e-cigarettes, ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.